EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update
Smolen, J. S., Edwards, C. J., Konzett, V., Laskou, F., Aletaha, D., Caporali, R., Dörner, T., Hyrich, K. L., Mateus, E., Pope, J. E., Primdahl, J., de Souza, S., Stamm, T., Takeuchi, T., van der Heijde, D. S., Verschueren, P., Winthrop, K. L., Alvaro-Gracia, J. M., Askling, J. & Bathon, J.
& 30 others,
Buch, M. H., Burmester, G. R., Codreanu, C., Conaghan, P. G., Cutolo, M., Fautrel, B., Fonseca, J., Gossec, L., Haavardsholm, E., Hetland, M. L., Iagnocco, A., Juge, P.-A., Li, Z., Moe, R. H., Nash, P., Poór, G., Rubbert-Roth, A., Sobrin, R. D. S., Schulze-Koops, H., Shumnalieva, R., Senolt, L., Silva-Fernandez, L., Strangfeld, A., Taylor, P., Turesson, C., van Duuren, E., de Wit, M., Xavier, R., Kerschbaumer, A. & Landewé, R. B. .,
2026, (E-pub ahead of print)
In: Annals of the rheumatic diseases.Research output: Contribution to journal › Article › Academic › peer-review